Reaktion #356

ord-49953a76cfae45059ad30fb1a9e6e7be

Reaktionsgleichung

Brc1cncc(Br)c1
Brc1cncc(Br)c1
CNc1ccc(F)cc1
CNc1ccc(F)cc1
CN(c1ccc(F)cc1)c1cncc(Br)c1
CN(c1ccc(F)cc1)c1cnc
Ausbeute 12.5%

Lösungsmittel

Reaktionsbedingungen

Temperatur
110°CELSIUS

Vorschrift

In a 50 mL round-bottomed flask (t=g) was 4-fluoro-N-methylaniline (1 g, 7.99 mmol), 3,5-dibromopyridine (2.272 g, 9.59 mmol), and Pd2(dba)3 (0.366 g, 0.40 mmol) in toluene (16 mL) ([VOLUME]) to give a purple suspension. biphenyl-2-yldicyclohexylphosphine (0.420 g, 1.20 mmol) and KOtBu (1.166 g, 10.39 mmol) were added. Reaction was allowed to stir for 1.5 hours at which point LC/MS was taken which indicated that all the dibromopyridine had been consumed. Reaction was quenched by addition of excess ammonium chloride. Mixture was filtered though a plug of celite, extracted with ethyl acetate. The organic fractions were collected and washed with water, then dried over NaSO4, rotovapped down to an oil, redissolved in DCM then purified over a 120g column using 5 minutes of pure hexane, followed by a 0-50% EtOAc gradient (product comes off at around 35%). The relevant fractions were collected and rotovapped down yielding the product as an oil.

Quelle

750 AstraZeneca ELN dataset